PharmingoGet the app
Nutrition · Potassium

Hypokalaemia: Safe Replacement and the Magnesium Link

Potassium is the most abundant ion inside your cells, and the gradient it holds across every membrane is what lets nerves fire and the heart beat in rhythm. Move that number a little — a diuretic here, a bout of vomiting there — and the same ion that runs the heart can stop it. Hypokalaemia is one of the commonest electrolyte disturbances on any ward, and much of it is made by the drugs we prescribe. This chapter is about reading the danger early, replacing potassium without killing the patient in the process, and the one companion ion — magnesium — that quietly decides whether your replacement works at all.

14 min read🎯 Linked lesson: Hypokalaemia· Updated 2026-07-18
THE SCENE

A 71-year-old woman on a thiazide for her blood pressure is admitted after two days of vomiting from a stomach bug. She feels profoundly weak, her legs "like lead," and the ward nurse notes her abdomen is silent and distended — her bowel has gone quiet. The junior doctor glances at the monitor and frowns: the T waves have flattened and there is a small extra hump after each of them, a U wave. Her potassium comes back at 2.6 mmol/L. She is also on digoxin for atrial fibrillation, and the registrar's first worry is not the weakness or the ileus but the heart — because low potassium and digoxin are a dangerous pair. Two forces have converged on her: a diuretic wasting potassium through the kidney, and vomiting stripping more through the gut. The fix seems obvious — give potassium back — but how you give it is a question that has killed patients.

Why a low number is a cardiac problem

Potassium sets the resting voltage of every excitable cell. The steep potassium gradient across the cell membrane — high inside, low outside — is what fixes the resting membrane potential. Lower the outside K+ and that gradient distorts, changing how easily cells depolarise and, crucially, how they repolarise afterwards. In skeletal muscle the effect is weakness, cramps and, when severe, frank paralysis. In smooth muscle the gut slows and can stop altogether — an ileus, the silent distended abdomen. But the organ that matters most is the heart. Hypokalaemia prolongs and destabilises repolarisation, and the myocardium becomes electrically irritable: ectopic beats, then re-entrant arrhythmias, and at the extreme ventricular tachycardia or fibrillation. This is why a bald number on a lab report is treated as an emergency long before the patient looks like one.

The electrocardiogram gives away the disorder before catastrophe. The classic sequence is flattening of the T waves, the appearance of U waves (a small deflection after the T), ST-segment depression, and a prolonged apparent QT. None of these is subtle once you look for them, and on a patient on digoxin they are a fire alarm — because low potassium dramatically potentiates digoxin toxicity. Digoxin and potassium compete for the same site on the Na+/K+-ATPase pump; when potassium falls, digoxin binds more avidly, and a dose that was perfectly safe yesterday becomes toxic today. The Cardiovascular chapter on cardiac glycosides treats this interaction in full — but the one-line rule is worth carrying everywhere: never let the potassium run low in a patient on digoxin.

THE ANALOGY

Think of the cell membrane like a dam holding back a full reservoir of potassium. The height of the water behind it — the gradient — is what keeps the turbines (the heart's electrical machinery) turning smoothly. Hypokalaemia doesn't just lower the water; it makes the whole system twitchy, so the turbines surge and stall unpredictably. And digoxin is like partially jamming the pump that maintains the wall: on a full reservoir the jam is tolerable, but drop the water level and the same jam threatens to bring the whole structure down.

Where the potassium goes — the four routes

Every cause of hypokalaemia is a story of loss, shift, or poor intake. The largest cause by far is renal loss, and here pharmacology dominates: loop and thiazide diuretics are the classic culprits, forcing sodium and water out and wasting potassium along the distal nephron. Mineralocorticoid excess does the same through aldosterone — primary hyperaldosteronism (Conn's syndrome), Cushing's syndrome, and, memorably, liquorice, whose active compound blocks the enzyme that normally protects the kidney from cortisol and so mimics aldosterone. The Endocrine section on the adrenal cortex covers Conn's and Cushing's in detail. The second route is gastrointestinal loss: vomiting, diarrhoea, and laxative abuse strip potassium from the gut (vomiting also drives renal loss indirectly, through the alkalosis and volume depletion it creates).

The third route catches people out because the body's total potassium hasn't changed at all — it has simply shifted into cells. Insulin drives potassium inward (which is exactly why insulin-with-glucose is a treatment for the opposite problem, hyperkalaemia); beta-2 agonists such as salbutamol do the same; alkalosis pushes potassium into cells in exchange for hydrogen ions; and the most dangerous version of all is refeeding syndrome, where feeding a starved patient triggers a surge of insulin that sweeps potassium, phosphate and magnesium into cells at once. The Refeeding-syndrome chapter is essential reading precisely because the shift can crash the potassium hours after the first meal or infusion. The fourth and least common route is simply poor intake — rare on its own, because healthy kidneys conserve potassium well, but it compounds every other cause in the malnourished, the alcohol-dependent, and the elderly.

Key points
  • Hypokalaemia is dangerous chiefly through the heart: it destabilises repolarisation and provokes arrhythmias.
  • ECG signature: flattened T waves, U waves, ST depression, apparent QT prolongation.
  • It potentiates digoxin toxicity — the two compete at the Na+/K+-ATPase; never run K+ low on digoxin.
  • Renal loss dominates: loop and thiazide diuretics, and mineralocorticoid excess (Conn's, Cushing's, liquorice).
  • Also GI loss (vomiting, diarrhoea, laxatives), transcellular shift (insulin, salbutamol, alkalosis, refeeding), and poor intake.
  • Muscle weakness and ileus are the non-cardiac warning signs.

The magnesium rule: why replacement fails

The potassium that won't come up is nearly always hiding a low magnesium. This is the single highest-yield idea in the whole topic. Hypokalaemia and hypomagnesaemia travel together — the same diuretics, the same diarrhoea, the same alcohol dependence that waste one waste the other. But magnesium is not just a fellow traveller; it is mechanistically upstream. Low magnesium releases the brake on the renal outer-medullary potassium (ROMK) channels in the distal nephron, so the kidney leaks potassium it should be holding onto. The consequence at the bedside is brutally practical: if you replace potassium without correcting the magnesium, the kidney simply wastes the potassium you are giving, and the level will not budge. Refractory hypokalaemia — potassium that won't correct despite generous replacement — should make you check and correct the magnesium every single time. Replace both together. The Magnesium chapter develops this and the arrhythmia connection further.

💡 CLINICAL PEARL

If potassium refuses to rise despite adequate replacement, the answer is almost always magnesium. Low Mg2+ makes the kidney throw away the very potassium you're infusing, so you can pour it in and watch the level stay flat. Check magnesium in any refractory hypokalaemia — and in a symptomatic patient, don't wait for the result: replace both.

Replacing potassium without causing harm

The route matters as much as the dose. Wherever the patient can swallow and the deficit is mild or moderate, the oral route is preferred — potassium chloride salts, given as tablets or solution, replace the deficit safely and steadily. Chloride is usually the right anion because many hypokalaemic states (especially vomiting) are also chloride-depleted and alkalotic. Oral replacement almost never causes the dangerous overshoot that intravenous potassium can, which is exactly why it is the default. Reserve intravenous potassium for when the deficit is severe, the patient is symptomatic (arrhythmia, marked weakness, paralysis), or the oral route is unavailable — and then treat it with genuine respect.

Here is the cardinal safety rule, and it is absolute: intravenous potassium must be diluted and rate-limited. Concentrated or fast potassium delivered straight to the heart causes fatal arrhythmia and cardiac arrest — this is not a theoretical risk but a recurring cause of death from medication error. Potassium must never be given as a rapid IV bolus or "push." It is diluted in fluid, run at or below a maximum infusion rate, and for higher rates given through a controlled infusion pump with continuous cardiac (ECG) monitoring, ideally into a larger vein. A useful mental anchor: the concentration and the speed are what kill, not the total amount — the same dose that heals over hours can stop the heart in seconds. Peripheral infusions are also kept relatively dilute because concentrated potassium is intensely irritant to veins.

Correcting the cause, not just the number

Replacement buys time; fixing the cause prevents the relapse. If a loop or thiazide diuretic is wasting potassium, the options are to reduce or stop it, or to add a potassium-sparing agent — spironolactone (an aldosterone antagonist) or amiloride (which blocks the distal sodium channel) — which raise potassium while keeping the diuretic effect. These agents are the subject of the Cardiovascular / Diuretics chapter, and they are exactly the drugs you must not stack blindly, because in the wrong hands they cause the opposite emergency. If the driver is mineralocorticoid excess, treat that directly: spironolactone for Conn's, addressing the cortisol source in Cushing's, stopping the liquorice. The principle is the bookend of the hyperkalaemia chapter — both extremes of potassium are cardiac emergencies, and every intervention must be checked against the risk of overshooting into the opposite one.

Key points
  • Refractory hypokalaemia = check and correct magnesium; low Mg2+ makes the kidney waste K+.
  • Oral potassium chloride is the preferred, safer route for mild-to-moderate deficits.
  • IV potassium is for severe/symptomatic cases or when oral isn't possible.
  • Cardinal rule: IV potassium must be dilute and rate-limited — never a rapid bolus/push.
  • High infusion rates need a controlled pump and continuous cardiac monitoring.
  • Correct the cause: reduce/stop the diuretic, add a potassium-sparing agent, treat mineralocorticoid excess.
⚠️ Common mistakes
  • Giving concentrated or fast IV potassium — the classic lethal error; potassium must always be dilute and rate-limited, never pushed.
  • Chasing a stubborn potassium with ever more replacement while ignoring the magnesium that is causing the kidney to waste it.
  • Forgetting the digoxin patient — allowing potassium to drift low, which precipitates digoxin toxicity and arrhythmia.
🎓 Questions students ask
Why not always just give potassium intravenously — isn't it faster and more reliable?
Because the intravenous route carries the real risk of a fatal overshoot that the oral route almost never does. Oral potassium is absorbed gradually, giving the body time to distribute it; IV potassium delivered too fast or too concentrated can arrest the heart. Unless the patient is severely depleted, symptomatic, or unable to swallow, oral replacement is both safe and adequate — reserve IV for when you truly need it, and even then keep it dilute and slow.
The potassium keeps dropping despite replacement — what am I missing?
Magnesium, until proven otherwise. Low magnesium unlocks renal potassium channels so the kidney throws away whatever you replace, and no amount of potassium alone will hold. Check the magnesium and replace it alongside the potassium. Also reconsider ongoing losses — a diuretic still running, continuing diarrhoea, or an unrecognised mineralocorticoid excess — because you can't win a race against a loss you haven't stopped.
How does low potassium interact with digoxin exactly?
Digoxin works by binding the Na+/K+-ATPase, and potassium competes with it at the same site. When potassium is low there is less competition, so digoxin binds more and its effect — including its toxicity — is amplified. A patient can slide into digoxin toxicity on an unchanged dose simply because their potassium fell. That is why you keep potassium in the normal range in anyone on digoxin, and why hypokalaemia plus digoxin is treated as a genuine emergency.
Test yourself

A patient on a loop diuretic and digoxin has a potassium of 2.7 mmol/L that fails to rise despite two days of oral and intravenous potassium replacement. What is the most likely reason the replacement is not working?

🫁 In one breath
  • Hypokalaemia is common and often drug-induced (loop/thiazide diuretics); its main danger is cardiac — arrhythmias, with an ECG of flat T waves, U waves and ST depression — and it potentiates digoxin toxicity.
  • Causes: renal loss (diuretics, mineralocorticoid excess — Conn's, Cushing's, liquorice), GI loss (vomiting, diarrhoea, laxatives), transcellular shift (insulin, salbutamol, alkalosis, refeeding), and poor intake.
  • The magnesium rule: hypokalaemia that won't correct is usually hiding a low magnesium — replace magnesium to fix refractory potassium.
  • Replace potassium orally where possible; IV only when severe/symptomatic and always dilute and rate-limited (never a rapid push) with cardiac monitoring — and correct the underlying cause.
📚 Sources
  • Rang & Dale's Pharmacology — Diuretics; the kidney and potassium handling.
  • Katzung Basic & Clinical Pharmacology — Diuretic agents; digitalis and potassium interaction.
  • British National Formulary (BNF) — Potassium chloride; oral and intravenous potassium; fluids and electrolytes.
  • UK Kidney Association (Renal Association) clinical practice guidelines — treatment of acute hyperkalaemia and disorders of potassium.
  • Huang CL, Kuo E. Mechanism of hypokalemia in magnesium deficiency. Journal of the American Society of Nephrology.
  • Ganong's Review of Medical Physiology — membrane potential and potassium; cardiac electrophysiology.

More in Potassium →

Learn pharmacology and anatomy the fun way

Short lessons, interactive quizzes, a real 3D anatomy model, and a streak you'll actually keep.

Download on the App StoreGet it on Google Play